Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Genzyme in Icahn's Sights
TheStreet.com
Monday, February 22, 2010 - 9:25am
tags:
Genzyme, Carl Icahn
Early Earnings Winners: Endo Pharma
TheStreet.com
Monday, February 22, 2010 - 9:24am
tags:
Endo, earnings
Novartis gets FDA approval for Menveo
Marketwatch
Monday, February 22, 2010 - 9:22am
tags:
FDA, vaccines, Novartis, Menveo
Glaxo Falls on U.S. Report Over Avandia’s Heart Risk
Bloomberg
Monday, February 22, 2010 - 9:22am
tags:
GSK, Avandia
Dendreon Redux
Seeking Alpha
Sunday, February 21, 2010 - 11:15am
tags:
Dendreon, Provenge, prostate cancer
Barclays raises Teva target price
Globes, Israel
Sunday, February 21, 2010 - 11:13am
tags:
Teva Pharmaceuticals
NasVax signs flu vaccine deal with Novartis
Globes, Israel
Sunday, February 21, 2010 - 11:12am
tags:
NasVax, Novartis, swine flu
SOLVAY : Operating result in the fourth quarter (EUR 313 million) clearly improved compared to last
PR-USA.net
Sunday, February 21, 2010 - 11:09am
tags:
Solvay
There's a sea change coming
Jerusalem Post, Israel
Sunday, February 21, 2010 - 11:08am
tags:
pharma industry
Senate Report: Glaxo Knew of Avandia Risks
The Street
Sunday, February 21, 2010 - 10:56am
tags:
Avandia, GSK, diabetes
Controversial Diabetes Drug (Avandia) Harms Heart, U.S. Concludes
NY Times
Saturday, February 20, 2010 - 11:52am
tags:
Avandia, GSK, diabetes
GSK Receives Positive Opinions In Europe For Tyverb® (lapatinib) And Votrient™ (pazopanib)
Medical News Today
Saturday, February 20, 2010 - 11:50am
tags:
GSK, Tyverb, Votrient, breast cancer
Chugai Pharma to develop & commercialize cancer drug GDC-0449 in Japan
Pharmabiz
Saturday, February 20, 2010 - 11:48am
tags:
Chugai, Curis, Genentech, colorectal cancer, ovarian cancer
EPO: Dosage Regime Patentable Even If It is The Only Novel Feature
Patent Baristas
Saturday, February 20, 2010 - 11:44am
tags:
patents
SAC Capital turns the tables on Biovail
Reuters
Saturday, February 20, 2010 - 11:42am
tags:
Biovail
FDA Classifies Prolia(TM) (Denosumab) Complete Response Submission and Targets Action Date
Yahoo/PR NewsWire
Saturday, February 20, 2010 - 11:40am
tags:
Amgen, Prolia
Life Technologies Announces Completion of $1.5 Billion Senior Notes Offering
Yahoo/BusinessWire
Saturday, February 20, 2010 - 11:39am
tags:
Life Technologies
La Jolla Pharmaceutical Company Provides Responses to Frequently Asked Questions about Merger Vote
Yahoo/BusinessWire
Saturday, February 20, 2010 - 11:37am
tags:
La Jolla Pharmaceutical, Adamis Pharmaceuticals, M&A
Biogen drug OK'd for leukemia treatment
bizjournals.com
Saturday, February 20, 2010 - 11:01am
tags:
Biogen Idec, Rituxan, Genentech, leukemia
Drug stocks turn higher; Shire, XenoPort gain
MarketWatch
Saturday, February 20, 2010 - 10:58am
tags:
Shire, XenoPort

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.